EUVIMEDEUVIMED entdecken
Crossref

VRK3 promotes KSHV infection by suppressing the antiviral type I interferon response

Blossom Damania, Caroline J. Yu

UNC Libraries · 06.08.2026

DOI: 10.17615/t6q4-by79 ↗

Kurz gefasst

Fachartikel in der Zeitschrift UNC Libraries, erschienen am 06.08.2026. Verfasst von Blossom Damania und 1 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi sarcoma-associated herpesvirus (KSHV) is an oncogenic gammaherpesvirus that is associated with several human malignancies, and primary infection by KSHV can activate both DNA and RNA sensing pathways. Host innate immunity is a rapid, first-line defense against foreign pathogens, where pattern recognition receptors detect virus-associated antigens and activate the type I interferon response to prime the cell to an antiviral state to limit viral infections. However, viruses such as gammaherpesviruses, have evolved mechanisms to co-opt host factors to antagonize these pathways to promote persistent infection. The cellular vaccinia-related kinase (VRK) family is a trio of serine/threonine kinases, VRK1, VRK2 and VRK3, named for their homology to the vaccinia virus B1 kinase. The VRKs are involved in many cellular processes, including nuclear envelope assembly during mitosis and the DNA damage response. However, the role of the VRKs in KSHV infection and innate immunity has not previously been explored. We found that VRK3 is upregulated in response to KSHV primary infection of endothelial cells. VRK3 is also upregulated during KSHV reactivation from latency. Knockdown of VRK3 limited KSHV primary infection and lytic reactivation and resulted in increased activation of TBK1 and IRF3 and subsequent upregulation of interferon stimulated genes. Overexpression of VRK3 reversed this phenotype. Furthermore, we are also the first to demonstrate that VRK3 is a negative regulator of the interferon response even in the absence of viral infection. Collectively, our data highlight the importance of the host factor, VRK3, as a novel suppressor of the type I interferon response during the KSHV viral lifecycle.

Schlagwörter

Kaposi's sarcoma-associated herpesvirustype I interferon responseinnate immunitygammaherpesvirus infectionlytic reactivationTBK1IRF3interferon-stimulated geneshost-virus interactionendothelial cells

Zitieren

APA

Damania, B., & Yu, C. J. (2026). VRK3 promotes KSHV infection by suppressing the antiviral type I interferon response. UNC Libraries. https://doi.org/10.17615/t6q4-by79

Vancouver

Damania B, Yu CJ. VRK3 promotes KSHV infection by suppressing the antiviral type I interferon response. UNC Libraries. 2026. doi:10.17615/t6q4-by79

BibTeX
@article{Damania2026,
  author = {Damania, Blossom and Yu, Caroline J.},
  title = {VRK3 promotes KSHV infection by suppressing the antiviral type I interferon response},
  journal = {UNC Libraries},
  year = {2026},
  doi = {10.17615/t6q4-by79}
}
Kostenlos starten →